C57BL/6 Mouse Lymphatic Endothelial Cells

C57BL/6 Mouse Lymphatic Endothelial Cells

Cat.No.: CSC-C1870

Species: Mouse

Source: Lymph Node

Cell Type: Endothelial Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C1870
Description
C57BL/6 Mouse Lymphatic Endothelial Cells from Creative Bioarray are isolated from lymph node tissue of pathogen-free laboratory mice. C57BL/6 Mouse Lymphatic Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 1x10^6 cells per ml and are delivered frozen. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with LYVE1 antibody, following the application of magnetic beads pre-coated with secondary antibody.
Species
Mouse
Source
Lymph Node
Recommended Medium
Complete Mouse Endothelial Cell Culture Medium
Cell Type
Endothelial Cell
Disease
Normal
Quality Control
C57BL/6 Mouse Lymphatic Endothelial Cells are tested for expression of markers using antibody, VE-cadherin (CD144, VE-cadherin Antibody, C-19, sc6458, Santa Cruz); AF1002 (R&D System), CD31/PECAM-1 (Purified Rat Anti-Mouse CD31, Catalog No. 553370, BD) or LYVE-1 (Catalog No. ab9498, Abcam) by immunofluorescence staining or FACS. C57BL/6 Mouse Lymphatic Endothelial Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-6 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

C57BL/6 mouse lymphatic endothelial cells (LECs) are primary lymphatic endothelial cells isolated from lymphatic-rich tissues of the C57BL/6 inbred strain, including lymph nodes, dermis, lung, or mesentery. They retain canonical lymphatic markers—LYVE-1, podoplanin (PDPN), PROX1, and VEGFR-3 (FLT4)—and key functions such as VEGF-C/VEGFR-3–dependent proliferation, migration, tube formation in three-dimensional matrices, and responsiveness to inflammatory cytokines and shear stress. As non-immortalized primary cells, they better preserve native signaling, transcriptional profiles, and strain-specific responses than immortalized LEC lines.

Compared with xenogeneic systems, C57BL/6 LECs provide a defined genetic background and excellent compatibility with syngeneic C57BL/6 mouse models, immune cells, and tumor lines. This reduces allogeneic variability and supports mechanistic studies of lymphangiogenesis, immune cell trafficking, antigen transport, and lipid homeostasis. They are widely used in cancer metastasis, lymphedema, chronic inflammation, autoimmune disease, transplant rejection, and drug discovery. Their defined background also facilitates comparison with widely used knockout, transgenic, and reporter models.

Decorin Evokes a Pro-Lysosomal Pathway in Lymphatic Endothelial Cells

The lymphatic system is critical to the body's immune and circulatory system, and lymphangiogenesis, the development of new lymphatic vessels from pre-existing ones, is a significant process capitalized upon by cancer during tumorigenesis. Decorin is a small leucine-rich proteoglycan which we have previously shown to be anti-tumorigenic and a suppressor of lymphangiogenesis. We have also shown that decorin exercises its anticancer properties through its ability to evoke autophagy. Through a comprehensive and unbiased proteomic analysis, we explored the implications of decorin exposure on protein expression within mouse lymphatic endothelial cells. We discovered that decorin enriches several protein pathways, notably proteasomal degradation and lysosomal pathways. Several proteins within these pathways such as lysosome associated membrane protein 1 (Lamp1) and Neural precursor cell expressed developmentally downregulated protein 8 (Nedd8) were differentially regulated following decorin treatment. These proteins and their functional pathways should be considered therapeutic targets and emerge as candidates for further exploration within the context of decorin and cancer suppression.

Decorin Evokes a Pro-Lysosomal Pathway.
Fig. 1. Elucidation of the decorin-Lamp1 relationship (Pascal, Gabriel J., et al., 2025).
Can you send me exemplary quality control data (any lot) on these cells?

C57BL/6 Mouse Lymphatic Endothelial Cells from Creative Bioarray are tested for expression of markers using antibody, VE-cadherin, AF1002, CD31/PECAM-1 or LYVE-1 by immunofluorescence staining or FACS.

How many further passages we might expect from the cells?

Cells can be expanded for 3-6 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products